GRANULOCYTOPENIA, ANEMIA AND THROMBOCYTOPENIA
See full prescribing information for complete boxed warning.
- Trade Names: Cymevan; Cymeven; Cymevene; Cytovene (Roche); Vitrasert
- Indications: Cytomegalovirus retinitis in immunocompromised patients
- Class: Antiviral, Guanine nucleoside analog
- Half-life: 2.5–3.6 hours
- Clinically important, potentially hazardous interactions with:
Abacavir, Amphotericin B, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Alafenamide, Cobicistat/Elvitegravir/Emtricitabine/Tenofovir Disoproxil, Dapsone, Emtricitabine, Imipenem/Cilastatin, Imipenem/Cilastatin/Relebactam, Tenofovir Disoproxil, Zidovudine
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/20/2025
